Thalidomide, the notorious drug which caused horrendous birth defects in the 1950s and 1960s, is close to making a comeback as an anticancer drug. Drug firm Celgene of Warren, New Jersey, has applied to European drug authorities for permission to sell thalidomide to treat multiple myeloma, a fatal cancer of the bone marrow. In clinical trials the drug performed well against the disease. It will take Europe seven months or more to reach a verdict on the drug, which will not be prescribed to pregnant women or those considering having children.
To continue reading, today with our introductory offers
Advertisement
More from 快猫短视频
Explore the latest news, articles and features
Popular articles
Trending 快猫短视频 articles
1
Glaciers in the 'roof of the world' have suddenly started melting
2
Pancreatic cancer halted by virus injection in three patients
3
The best new science-fiction books of June 2026
4
Does gravity create reality? A shocking path to a theory of everything
5
How a radical new view of life could reveal its origin 鈥 and aliens
6
Why your brain needs plenty of 鈥淎ha!鈥 moments
7
Aim high but don't shoot for the moon, mathematicians advise
8
Start-ups are racing to revolutionise mathematics with AI
9
Photons behave very strangely if you try to cut them
10
Earliest use of anaesthetics uncovered in Chinese doctor鈥檚 tomb
